A systematic approach to the development of a safe live attenuated Zika vaccine
A Zika virus (ZIKV) vaccine should provide long-lasting immunity, which may be achieved with a live-attenuated vaccine. Here, Kwek et al. select an interferon-restricted, attenuated ZIKV variant and evaluate replication and immunogenicity in mouse and mosquito models.
Main Authors: | Swee Sen Kwek, Satoru Watanabe, Kuan Rong Chan, Eugenia Z. Ong, Hwee Cheng Tan, Wy Ching Ng, Mien T. X. Nguyen, Esther S. Gan, Summer L. Zhang, Kitti W. K. Chan, Jun Hao Tan, October M. Sessions, Menchie Manuel, Julien Pompon, Camillus Chua, Sharifah Hazirah, Karl Tryggvason, Subhash G. Vasudevan, Eng Eong Ooi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2018-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-018-03337-2 |
Similar Items
-
Dysregulated metabolism underpins Zika-virus-infection-associated impairment in fetal development
by: Clement Yau, et al.
Published: (2021-12-01) -
Tissue-specific expansion of Zika virus isogenic variants drive disease pathogenesisResearch in context
by: Kitti Wing Ki Chan, et al.
Published: (2023-05-01) -
Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection
by: Clement Yau, et al.
Published: (2020-11-01) -
A Zika virus from America is more efficiently transmitted than an Asian virus by Aedes aegypti mosquitoes from Asia
by: Julien Pompon, et al.
Published: (2017-04-01) -
Highly Efficient Vertical Transmission for Zika Virus in <i>Aedes aegypti</i> after Long Extrinsic Incubation Time
by: Menchie Manuel, et al.
Published: (2020-05-01)